Abstract:Objective To Observe dynamically the level of CD_4~+ CD_(25)~+ Tregs in the peripheral blood in patients with liver failure receiving artificial liver support system and/or medical treatment and investigate the relationship between the level of CD_4~+ CD_(25)~+ Tregs and curative effect and prognosis.Methods Sixty-three patients with liver failure were divided into 2 groups according to the treatment protocol:medical treatment combined with artificial liver support system(combined group)(29 cases)and medical treatment only group (medical group)(34 cases).According to indicators such as liver function and clinical symptoms etc,there were 17 effective cases and 12 ineffective cases in the combined group while 11 effective cases and 23 ineffective cases in the medical group.23 healthy donors were used as normal control group.The level of CD_4~+ CD_(25)~+ Treg in the peripheral blood was measured by flow cytometry dynamically and the relationship between the level of CD_4~+ CD_(25)~+ Treg and curative effect was analyzed accordingly.Results The Treg level was(2.46±0.56)% in the normal control group.For those effective groups,the Treg level before treatment was lower compared to normal control group,it was(1.92±0.78)% and(2.10±0.56)% in combined group and medical group respectively.There was no significant difference between these two groups (P0.05)although it was statistically significant when both compared to the normal control group(P 0.05);After treatment,the Treg level in the effective groups was(2.62±0.67)%(combined group)and (2.89±0.72)%(medical group)respectively.There was significant difference between these two groups (P0.05)while no statistical significant was found when compared to the normal control group(P 0.05);Both effective groups showed significant difference before and after the treatment(P0.05);As to the ineffective groups,the Treg level was higher before treatment compared to the normal control.It was (4.64±1.31)%(combined group)and(4.87±2.86)%(medical group)respectively.There was no significant difference between these two groups(P0.05)while it was statistical significant when compared to the normal control group(P0.05);After treatment the Treg level in the ineffective groups was(5.44± 2.13)%(combined group)and(5.91±2.78)%(medical group)respectively.There was no significant difference between these two groups(P0.05)although it was statistically significant compared to the normal control group(P0.05).There was significant difference before and after the treatment in both ineffective groups(P0.05).The change of Treg level appeared to show low-high-low peaked curve in the effective groups and it recovered to the normal level soon in the combined group compared to the medical treatment group.In the ineffective treatment groups,the change of Treg level appeared to be high-low-high notched curve.Conclusion The level of CD_4~+ CD_(25)~+ Treg was correlated with the curative effect and it may be used as a potential indicator for curative effect and prognosis in patients with liver failure.

Phenotypes and clinical significance of circulating CD4 + CD25 + regulatory T cells (Tregs) in patients with acute-on-chronic liver failure (ACLF)

Changes in Peripheral CD4+CD25 high Regulatory T Cells in the Acute-on-Chronic Liver Failure Patients with Plasma Exchange Treatment

The Frequency and Skewed T-Cell Receptor Beta-Chain Variable Patterns of Peripheral Cd4(+)Cd25(+) Regulatory T-Cells Are Associated with Hepatitis B E Antigen Seroconversion of Chronic Hepatitis B Patients During Antiviral Treatment

IMBALANCE BETWEEN CIRCULATING CD4(+) REGULATORY T AND CONVENTIONAL T LYMPHOCYTES IN PATIENTS WITH HBV-RELATED ACUTE-ON-CHRONIC LIVER FAILURE

The Ratio of Th-17 to Treg Cells is Associated with Survival of Patients with Acute-on-chronic Hepatitis B Liver Failure.

Effect of regulatory T cells and adherent cells on the expansion of HBcAg-specific CD8+ T cells in patients with chronic hepatitis B virus infection

Molecular features of the complementarity determining region 3 motif of the T cell population and subsets in the blood of patients with chronic severe hepatitis B

Frequency of Th17 and Treg in HBV-related acute-on-chronic liver failure and its clinical value

An Investigation on Relationship Between the Level of CD4+ CD25+ Regulatory T Cells in the Peripheral Blood and Curative Effect in Patients with Liver Failure

Imbalance of interleukin‐17‐producing <scp>CD</scp>4 <scp>T</scp> cells/regulatory <scp>T</scp> cells axis occurs in remission stage of patients with hepatitis <scp>B</scp> virus‐related acute‐on‐chronic liver failure

Restoring the Treg Cell to Th17 Cell Ratio May Alleviate Hbv-Related Acute-On-Chronic Liver Failure

Characteristics of Peripheral Lymphocyte Subsets in Patients With Acute-On-Chronic Liver Failure Associated With Hepatitis B

Increased numbers of CD5 + CD19 + CD1d high IL-10 + Bregs, CD4 + Foxp3 + Tregs, CD4 + CXCR5 + Foxp3 + follicular regulatory T (TFR) cells in CHB or CHC patients

Expression Levels of CD4~+CD25~+ Regulatory T Cells in Peripheral Blood of Patients with Chronic Hepatitis B and Clinical Significance

Dynamic changes of T cell receptor repertoires in patients with hepatitis B virus-related acute-on-chronic liver failure

Liver-targeted and Peripheral Blood Alterations of Regulatory T Cells in Primary Biliary Cirrhosis

Circulating and Liver Resident CD4+CD25+ Regulatory T Cells Actively Influence the Antiviral Immune Response and Disease Progression in Patients with Hepatitis B.

Analysis of the CD4 + CD25 high regulatory T cells in peripheral blood of chronic hepatitis B virus infected patients

Circulating Cd4(+) Cd25(+) Regulatory T Cells Correlate With Chronic Hepatitis B Infection

Imbalance of interleukin-17-producing CD4 T cells/regulatory T cells axis occurs in remission stage of patients with hepatitis B virus-related acute-on-chronic liver failure.

Effects of Regulatory T Cells on Anti-Viral Immune Responses Impaired by Chronic Hepatitis B